/PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from.
Inovio Pharma (INO) Reports Positive Phase 1b Results for INO-4201 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PHILADELPHIA (July 7, 2022) Under a Defense Advanced Research Projects Agency ( DARPA ) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense ( JPEO - CBRND ) funded program, a novel COVID -19 antibody delivery approach has advanced to clinical trials.
Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.